Old Web
English
Sign In
Acemap
>
authorDetail
>
Marco M. Gottardis
Marco M. Gottardis
Johnson & Johnson
Gene silencing
Small molecule
Cancer
Molecular biology
Cancer cell
2
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of JNJ-63576253, a next-generation androgen receptor antagonist active against wild-type and clinically-relevant ligand binding domain mutations in mCRPC
2021
Molecular Cancer Therapeutics
Jonathan Branch
Tammy L. Bush
Vineet Pande
Peter J. Connolly
Zhuming Zhang
Ian Hickson
Janine Ondrus
Steffen Jaensch
James R. Bischoff
Georges Habineza
Geert Van Hecke
Lieven Meerpoel
Kathryn Packman
Christopher J. Parrett
Yolanda T. Chong
Marco M. Gottardis
Gilles Bignan
Show All
Source
Cite
Save
Citations (0)
Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers.
2015
Experimental Cell Research
Michele Modugno
Patrizia Banfi
Fabio Gasparri
Robert M. Borzilleri
Percy H. Carter
Lyndon A.M. Cornelius
Marco M. Gottardis
Ving G. Lee
Claudio Mapelli
Joseph G. Naglich
Andrew J. Tebben
Gregory D. Vite
Wilma Pastori
Clara Albanese
Emiliana Corti
Dario Ballinari
Arturo Galvani
Show All
Source
Cite
Save
Citations (23)
1